cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Acumen Pharmaceuticals Inc
3 own
6 watching
Current Price
$3.17
$-0.3
(-8.65%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
199.79M
52-Week High
52-Week High
11.31000
52-Week Low
52-Week Low
1.81000
Average Volume
Average Volume
0.63M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization199.79M
icon52-Week High11.31000
icon52-Week Low1.81000
iconAverage Volume0.63M
iconDividend Yield--
iconP/E Ratio--
What does the Acumen Pharmaceuticals Inc do?
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer s disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Read More
How much money does Acumen Pharmaceuticals Inc make?
News & Events about Acumen Pharmaceuticals Inc.
TipRanks Financial Blog
1 year ago
In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Acumen Pharmaceuticals (ABOS Research Report), with a price t... In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Acumen Pharmaceuticals (ABOS &#8211...
Zolmax
1 year ago
Acumen Pharmaceuticals (NASDAQ:ABOS Get Rating) and Elevation Oncology (NASDAQ:ELEV Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, ...
Globe Newswire
1 year ago
Topline results including safety and proof-of-mechanism data expected in third quarter of 2023CHARLOTTESVILLE, Va. and CARMEL, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen or the Company), a clinical-stage biopharmaceutical company developing a novel ...
Zolmax
1 year ago
HC Wainwright restated their buy rating on shares of Acumen Pharmaceuticals (NASDAQ:ABOS Get Rating) in a report released on Thursday morning, Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. ABOS has been the subject of a number of other research reports. ...
Globe Newswire
1 year ago
CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen or the Company), a clinical-stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimers disease (AD), today announced Derrell ...
Frequently Asked Questions
Frequently Asked Questions
What is Acumen Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Acumen Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Acumen Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Acumen Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Acumen Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Acumen Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Acumen Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Acumen Pharmaceuticals Inc?
plus_minus_icon
What percentage is Acumen Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Acumen Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.17
$-0.3
(-8.65%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00